S 5682

Drug Profile

S 5682

Alternative Names: Alnenor; Alvenor; Ardium; Arvenum; Capivan; Capiven; Daflon; Detralex; Variton; Venitol

Latest Information Update: 23 May 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Servier
  • Class Antihistamines; Flavanones; Flavones
  • Mechanism of Action Antioxidants; Prostaglandin synthase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Haemorrhoids; Venous insufficiency

Most Recent Events

  • 24 Jun 2018 Biomarkers information updated
  • 02 May 2018 Servier initiates enrolment in a phase III trial for Venous-insufficiency in Hungary (EudraCT2017-003633-28)
  • 05 Nov 2003 Launched for Haemorrhoids in Belgium (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top